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The goal of this study was to address the effects of a change in contractility on indexes of LV contractility in mice. We assessed the sensitivity of contractile indexes to the following three interventions to alter cardiac contractility: 1) using an atrial pacing increase in heart rate (HR), which has a modest effect on contractility via the forcefrequency relation (FFR) (8, 10, 12, 16) ; 2) using infusion of an inotropic agent, dobutamine (␤-adrenergic agonist), which maximizes contractility; and 3) using an esmolol (␤-adrenergic antagonist) infusion to decrease contractility.
METHODS
Thirty-four male C57BL mice (12-24 wk) were used in this study. The experimental protocol was approved by the Ani- 
Animal Preparation and Procedures
Surgical procedures. Mice were anesthetized with a mixture of ketamine (100 mg/kg ip), xylazine (2.5 mg/kg ip), and heparin (5,000 U/kg ip) and additional smaller doses were given as needed. Animals were placed in supine position on a temperature-controlled surgical table to maintain rectal temperature at 37°C and were allowed to breathe spontaneously with 1 l/min of oxygen via nasal cone. Under a dissecting microscope (model SZ40, Olympus; Tokyo, Japan), the right jugular vein was isolated, and a 1-Fr bipolar pacing catheter (model EP118-2, NuMED; Hopkinton, NY) or a polyethylene-10 tube for dobutamine or esmolol infusion was advanced into the right atrium and secured with 8-0 Prolene (model M8753, Ethicon; Somerville, NJ). Atrial pacing was established using a stimulator (model SD9E, Grass Medical Instruments; Quincy, MA). For LV catheterization, the right carotid artery was dissected and cannulated with a 1.4-Fr micro-tipped combined PV catheter (model SPR-719, Millar Instruments; Houston, TX). The conductance catheter was advanced retrograde into the LV and secured with the 8-0 Prolene. The conductance catheter was positioned in the LV chamber as the proximal electrodes of the catheter were positioned below the aortic valve by monitoring the twodimensional (2-D) parasternal LV long axis imaged using echocardiography. The conductance signal was acquired online using data-acquisition software (BioBench version 1.0, National Instrument; Austin, TX) and analyzed off-line by analysis software (PVAN, version 2.7, 001-1031, Millar Instruments).
Echocardiography
The mice were placed in a slight left lateral decubitus position, and the transducer was placed on the chest while excessive pressure was carefully avoided. Transthoracic echocardiographic examinations were performed using a cardiac system equipped with a 15-MHz linear transducer (Sequoia C256 and 15L8, Acuson; Mountain View, CA). The 2-D parasternal LV long-axis images were obtained at the plane of the aorta and mitral valve with adequate visualization of the LV apex and the short-axis view was recorded at the level of the papillary muscles. After the short-axis view was ensured, 2-D targeted M-mode tracings were recorded through the anterior and posterior LV walls at a sweep speed of 200 mm/s. Pulsed-wave Doppler signals of LV outflow were obtained from apical four-chamber view and were recorded at a sweep speed of 200 mm/s. All images were digitally acquired and stored for off-line analysis.
Protocols
Pacing study. DETERMINATION OF HR AT WHICH LV PRESSURE DERIVATIVE OVER TIME IS MAXIMAL IN FFR. To achieve a modest increment of inotropy, the hearts were atrial paced to a HR (HR max) at which the first derivative of LV pressure (LVP) over time (dP/dt) was maximal by augmentation of the FFR. Although it has been reported that myocardial contraction and relaxation were enhanced modestly (13-15%) at HRs of 400-500 beats/min (8) , five mice were used to define HR max in this experimental setting because HRmax may differ significantly between strains of mice and between experimental conditions (11, 12, 16) . When hemodynamic stability was ensured after the insertion of pacing and conductance catheters, baseline data were recorded. Atrial pacing was then initiated at just above the sinus rhythm (SR) HR and was increased at 1-Hz increments until maximum dP/dt (dP/dt max) was visually decreased. The setting of the stimulator was 3 V with 2 m/s pulse-width duration.
ECHOCARDIOGRAPHY AT SR AND HRMAX. Six mice were studied. Echocardiography was performed during the intrinsic SR and atrial pacing at HR max.
LV CATHETERIZATION AT SR AND HRMAX. Another five mice were used in this LV catheterization protocol. After surgery and hemodynamic stabilization, baseline measurements were performed at SR. After atrial pacing was established at HR max and hemodynamic stability was ensured, a second set of measurements were performed. A small transverse abdominal incision was then made on the upper abdominal wall, and P-V relations were measured at HR max by transient occlusion of the inferior vena cava (IVC) with simple compression with the use of a cotton swab. Another set of P-V relation measurements were repeated at SR after termination of pacing and hemodynamic stabilization.
Dobutamine infusion study. Twelve mice were entered into this protocol. Echocardiography and catheterization were performed individually in two separate groups (6 mice in each group). After baseline measurements dobutamine was infused at a rate of 30 ng ⅐ g body wt Ϫ1 ⅐ min Ϫ1 through the right jugular vein. When hemodynamic stability was ensured during infusion, a second set of measurements were made.
Esmolol infusion study. Eleven mice (5 for echocardiography and 6 for catheterization individually) were used in this protocol. After baseline measurements, esmolol (ultrashort acting ␤-adrenergic antagonist) was infused intravenously at a rate of 10 mg ⅐ kg body wt ⅐ min Ϫ1 . This dose was defined in a pilot study using five mice. The criteria were to achieve a 10% decline in HR, a 30% decline in dP/dt, and reversibility of the effects after completion of the infusion.
Data Analysis and Contractile Parameters
Echocardiography. M-mode LV internal chamber dimension and posterior wall thickness were measured at end diastole (EDD) and end systole (ESD) using the leading-edge method of three consecutive cardiac cycles (6) . End diastole was defined at the peak of the QRS complex of the electrocardiogram. End systole was defined as the peak of posterior wall thickening. LV fractional shortening (%FS) in the minor axis was calculated as %FS ϭ (EDD Ϫ ESD) ϫ 100/EDD. LV volume at end diastole (EDV) and end systole (ESV) were calculated by the bullet method as EDV ϭ 0.85 Vcf is in circumferences per second and EjT is in seconds. Mean normalized systolic ejection rate (MNSER) was calculated as MNSER ϭ [(EDV Ϫ ESV)/EDV]/EjT, where MNSER is in ejections per second. V cf and MNSER were used to assess LV ejection performance.
Catheterization-derived indexes. The 1.4-Fr high-fidelity micromanometer catheter was calibrated with a mercury manometer at the beginning of each experiment. Baseline zero reference was obtained by placing the sensor in normal saline before insertion. LVP, HR, and ϮdP/dt max were determined with analysis software. Although dP/dt max has been widely used as a cardiac contractile parameter in murine cardiac physiology, it is well recognized that dP/dt max is load dependent, especially on changes in preload (13, 14) . On the other hand, previous studies (13, 14) have demonstrated that the slope of the dP/dt max-EDV relation (dP/dtmax-EDV) represents a sensitive but less load-dependent parameter of chamber contractility. In previous studies, the slope of this relationship increased and shifted leftward with increased contractility, and it decreased and shifted rightward with depressed contractility. ESPVR and E max also have been used historically to assess in vivo contractility. Although limited by dependence on cardiac size (if the heart increases in volume, ESPVR will decrease regardless of contractility) (2, 15, 18) , ESPVR and Emax are thought to be ideal in acute studies such as this one because the heart size, mass, and volume do not change throughout the study. Therefore, ESPVR, Emax, and dP/dt-EDV were used to evaluate in vivo load independent LV contractile performance.
The relative volume unit (RVU) calibrator (Millar Instruments) was used in this study to convert acquired voltage to resistance or relative volume units. Because resistance is the inverse of conductance, conductance was available. However, we instead chose to leave our acquired signal in resistance units because they approximate the blood volume. Because they do not represent absolute volume (because the myocardial contribution to the voltage signal has been ignored) we have used RVU to label the volume axis. Calibration of the offset has been previously performed by hypertonic saline dilution method to measure parallel conductance volume (Vp) (1, 5) and by matching of stroke volume (SV) to an independent standard (␣) (5) . However, in our study, with the use of a closed-chest model, Vp from surrounding organs, which is the offset term for calibration, varied widely by the amount and speed of the saline injection (data were not shown). Whereas the dominant source of Vp in mice is the LV wall itself and varies little with changes in RV volume (9) , Vp at steady-state condition significantly increased when afterload was increased even in the same mice (5). Moreover, because saline injection alters hemodynamics in the mouse, dualfrequency excitation is recommended to measure more accurate Vp (4) but is commercially unavailable at this time. The lack of the offset calibration has the disadvantage of failing to give precise estimation of volume intercepts of P-V relations but the slope of ESPVR, Emax, and dP/dt-EDV are independent of this calibration. For all of these reasons, we did not believe the Vp calculation would improve the accuracy of our measurements.
A correction for electric field inhomogeneity (␣) is relevant to the slope of ESPVR and could change under different conditions affecting our results. ␣ was calculated as echocardiography-derived SV/conductance SV in this study. The echocardiography-derived SV was calculated as aortic VTI ϫ CSA, where VTI is the velocity time integral by Doppler and CSA of the aortic valve by M-mode echocardiography. ␣ before/after pacing and off/on dobutamine was 8.03 Ϯ 0.49/ 7.97 Ϯ 0.36 [not significant (NS), P ϭ 0.93] and 7.81 Ϯ 0.30/7.82 Ϯ 0.12 (NS, P ϭ 0.97), respectively. ␣ off/on esmolol was 11.50 Ϯ 0.62/10.56 Ϯ 0.74 (NS, P ϭ 0.37). Although we used the same design of catheter in the esmolol protocol, the catheter had a different ␣. Importantly, although ␣ varied between catheters with different serial numbers, it was consistent with and without interventions in each protocol. Therefore, changes in parameters derived from PV relationships using three interventions were not affected by an intervention-induced change in ␣ in our studies.
To detect sensitivity of parameters to change in contractility, the percent change was calculated in all derived parameters as {[(value during the pacing or dobutamine infusion) Ϫ (baseline value)] ϫ 100}/(baseline value).
Statistics
Data are expressed as means Ϯ SE. Hemodynamic data were compared between baseline and during interventions in each protocol using a paired t-test. One-way analysis of variance (ANOVA) was used to compare the percent change in contractility between parameters. Data were further compared by Student-Newman-Keuls test whether ANOVA was significant. A P Ͻ 0.05 was considered statistically significant.
RESULTS

Determination of HR max
Incremental atrial pacing resulted in a significant increase and biphasic change in dP/dt max (Fig. 1) . HR max was 505 Ϯ 14 beats/min. We therefore used 505 beats/min as HR max for the pacing study protocol.
Pacing Study
Hemodynamic parameters at both HRs were shown in Table 1 . Figure 2 shows the percent change of the indexes in the mice. All parameters except for %FS showed a significant change. The dP/dt-EDV was the most affected (162.8 Ϯ 95.9% increase) by a change in LV contractility, followed by E max (67.9 Ϯ 12.2% increase). The percent change in the dP/dt-EDV was significantly greatest among the parameters. Echocar- Fig. 1 . Determination of heart rate (HR) at maximum of the first derivative of left ventricular (LV) pressure (dP/dt) from the forcefrequency relationship. Incremental atrial pacing resulted in a significant increase and then a decrease in dP/dtmax. HRmax was 505 Ϯ 14 beats/min. Regression line shows polynomial curve fitting. HRmax, HR at which ϩdP/dtmax is maximal by augmentation of the forcefrequency relationship.
diography-derived global systolic parameters, such as %FS and EF%, had very small percent changes (10.2 Ϯ 6.3% and 16.6 Ϯ 5.3%, respectively). The dP/dt at HR max versus SR (8,549 Ϯ 780 and 6,080 Ϯ 715 mmHg/s, respectively, P Ͻ 0.05) also increased significantly. The percent change in ejection performance expressed as V cf and MNSER (42.2 Ϯ 8.0% and 51.9 Ϯ 5.6%, respectively) significantly increased after the pacing.
Dobutamine Study
Hemodynamic parameters at baseline and during dobutamine infusion were shown in Table 2 . Figure 3 shows the percent change of the indexes. Dobutamine significantly increased contractile parameters with a large percentage of change except for ESPVR and E max , where changes were inconsistent during dobutamine infusion. Again, dP/dt-EDV was the most affected (271.0 Ϯ 44.0% increase) by changes in LV contractility among the parameters and was followed by V cf and MNSER (103.5 Ϯ 23.6% and 71.3 Ϯ 4.8%, respectively). Figure 4 shows a representative echocardiogram during dobutamine infusion and IVC occlusion, which explains the inconsistency in ESPVR. The proximal pair of electrodes was moved out from the small LV cavity during this maneuver. Figure 5 shows representative P-V loops during dobutamine infusion and IVC occlusion. All loops have a spike at the corner of end systole, which indicates interference between pressure manometer and the LV endocardial surface. The lowest P-V loops shift to the right of the ESPVR line because the proximal sensing electrodes were positioned above the aortic valve. These anatomic findings were observed only during dobutamine infusion, which caused tachycardia and small ventricular cavity in end systole.
Esmolol Study
Hemodynamic and LV functional parameters at baseline and during esmolol infusion are shown in Table 3 . Figure 6 demonstrates the percent change of the contractile indexes. Although esmolol significantly reduced LV contractility detected by catheterizationderived indexes, %FS and EF% failed to detect the changes in contractility. The percent change in %FS, EF%, V cf , and MNSER were very small (%change: Values are means Ϯ SE. HR, heart rate; %FS, percent fractional shortening; EF%, percent ejection fraction; Vcf, myocardial velocity of LV circumferential shortening [in circumferences (circ)/s]; LVP, LV pressure; MNSER, mean normalized systolic ejection rate; dP/dt and ϪdP/dt, positive and negative peak rate of pressure development; , time constant of isovolumic relaxation by the Weiss method; ESPVR, end-systolic pressure-volume relationship; Emax, maximum chamber elasticity; dP/dt-EDV, slope of ϩdP/dtmax-EDV relation; HRmax, maximum HR at dP/dt. Values are means Ϯ SE. Ϫ8.7 Ϯ 3.9, Ϫ11.4 Ϯ 4.9, Ϫ14.5 Ϯ 3.0, and Ϫ14.8 Ϯ 3.9, respectively) and consistent with those in the pacing protocol. Interestingly, ESPVR was the most affected among the indexes (%change: Ϫ49.8 Ϯ 8.3) but was not significantly greater than the change in E max and dP/ dt-EDV (%change: Ϫ41.9 Ϯ 10.9 and Ϫ40.8 Ϯ 10.7, respectively).
DISCUSSION
There were four major findings of this study. First, load-independent parameters derived from P-V relationships were the most affected by a change in LV contractility. Second, %FS failed to detect the changes in contractility produced by pacing and esmolol infusion. Third, HR has a modest but significant effect on murine LV contractility measured by P-V relationderived parameters at relatively lower HR in this study. Fourth, the catheter used in this study caused artifactual malpositioning of the electrodes outside the small LV cavity caused by dobutamine infusion.
Echocardiographic Indexes
FS has been used in many murine studies because it is convenient and easy to understand. %FS is most useful in studies of transgenes, which have caused dramatic changes in cardiac phenotype. In our study, dobutamine, a strong inotrope, caused a significant change in %FS. However, %FS could not detect the difference in contractility increased by pacing at HR max or decreased during esmolol infusion. These results suggest that %FS would be ineffective in detecting small changes in contractility in murine models. In contrast, both mean V cf and MNSER consistently showed a significant change in all three settings of this study. However, because both indexes are also afterload sensitive (10, 21) , the relation with end-systolic stress needs to be assessed when a significant difference in the wall stress among groups is expected, such as in severe hypertrophy and hypertension. . The proximal pair of electrodes (left) was moved out the LV cavity in end systole during dobutamine infusion, whereas all electrodes were below the aortic valve inside the LV cavity at baseline. The size of the LV cavity was very small due to IVC occlusion and tachycardia with hypercontractility caused by dobutamine. This phenomenon was not observed in the other protocols. Fig. 5 . Representative pressure-volume (P-V) loops during IVC occlusion under dobutamine infusion. All loops have a spike in end systole (*), which indicates interference between pressure manometer and the LV endocardial surface. The lowest P-V loops sift to the right of the ESPVR line because of the proximal sensing electrode positioned above the aortic valve (arrow). This finding was observed only during IVC occlusion during dobutamine infusion, which caused a small ventricular cavity in end systole. l, Noncalibrated relative volume unit (RVU); Pes, end-systolic pressure; Ves, end-systolic volume. Values are means Ϯ SE.
Catheterization Indexes
Pacing at HR max or dobutamine significantly increased dP/dt max compared with baseline in this study. On the other hand, dP/dt max was significantly decreased during esmolol infusion. However, caution must be used in assessing LV contractility using dP/ dt max because of substantial load dependence (9) . Georgakopoulus et al. (7) (8) (9) showed that reducing EDP by only 1 mmHg from resting baseline was sufficient to lower dP/dt max by 18 Ϯ 5.2%. Thus parameters of LV contractile performance independent from or corrected for preload, such as ESPVR and E max (18) and dP/ dt max -EDV (14) established in larger animals, are also needed in making murine measurements of contractility. Whereas these parameters can be defined only by simultaneous measurement of pressure and volume, technical advances of microtipped combined PV catheters in the mouse have made it possible to obtain these parameters in vivo. These parameters increased significantly at HR max and decreased significantly during esmolol infusion. The slope of dP/dt max -EDV changed the most among the parameters we studied in the pacing and the dobutamine studies. This finding was supported by a previous report using an isolated canine heart model with carefully controlled alterations in preload and afterload. The dP/dt-EDV appeared an excellent choice to address contractility because of its marked sensitivity to inotropic change, its lack of preload dependence, and its minimal afterload dependence in the physiological range (13) . On the other hand, in the current study, dP/dt-EDV changed similarly to ESPVR and E max during esmolol infusion. The possible explanation in the differential response of dP/dt-EDV between positive and negative inotropy remains unclear.
In the dobutamine infusion protocol, the end-systolic parameter E max failed to show significant increase and consistent percent change. As seen in Fig. 4 , the small LV cavity caused malpositioning of the catheter electrodes outside the LV cavity, which led to an artifact on the volume signal (Fig. 5) . Therefore, caution must be used in assessing ESPVR parameters in small LV cavities using the P-V catheter that we used in this study. In future catheter redesign, spacing electrodes for small LV size will obviate this problem.
In this study, the lack of the offset calibration had the disadvantage of failing to give a precise estimation of volume intercepts (V o ) of PV relations. Because V o varies under different loading conditions (e.g., afterload shifts V o to the left, whereas preload shifts it to the right), it is valuable to determine V o in the P-V plane analysis. Therefore, the results of P-V relationderived parameters in this study will need to be verified when dual frequency conductance system is available.
Effects of HR on Cardiac Performance in Mice
In the present study, HR was used to assess the effect of a modest inotropic stimulus on performance based on the known effects on force of increasing frequency. Georgakopoulos and Kass (8) reported that contraction (dP/dt max ) and relaxation (time constant of isovolumic relaxation, ) were enhanced modestly (13-15%) at HRs of between 400 and 500 beats/min and ESPVR rose 35% at HRs from 400 to 600 beats/min. We noted similar changes in FFR and ESPVR. Georgakopoulos and Kass (8) noted that within the broad physiological HR (500-850 beats/min), by normalizing dP/ dt max by instantaneous developed pressure to diminish preload dependence, the biphasic HR-dP/dt relationship, especially the descending limb of the regular FFR, become flat. Accordingly, there was very little change in ESPVR at HRs Ͼ500 beats/min (8) . They concluded that the normal mouse has a very limited force-frequency reserve at physiological HRs unlike larger mammals. Interestingly, however, although we did not test the effects of a wide range of physiological HRs on contractile function, the HR at which the normalized FFR plateaued (ϳ500 beats/min) in the previous study (8) was similar to HR max in this study.
The positive inotropic response in the upslope of FFR is possibly explained by an increase in Ca 2ϩ availability to the contractile filaments as a result of increased Ca 2ϩ storage in the sarcoplasmic reticulum (SR) with augmentation of subsequent Ca 2ϩ transients (20) . Interestingly, it is demonstrated that the recirculation fraction of Ca 2ϩ was 93 Ϯ 1% in intact mice (much higher than the 50% in larger animals), which implies a more dominant role of SR buffering compared with other source of Ca 2ϩ (8) . It is also widely known that depressed FFR with abnormal Ca 2ϩ handling by the sarcoplasmic reticulum and the Na ϩ /Ca 2ϩ exchanger pump play a major role in human (17) and experimental heart failure (22) . Therefore, it is not surprising that FFR and HR max can vary in different settings of heart failure and in various transgenic mice in which gene modification affects intracellular Ca 2ϩ homeostasis and SR function.
In conclusion, contractile parameters derived from P-V relations are most sensitive to change in LV contractility and should be used especially to detect a small change in contractility. This study also identified limitations of echocardiographically derived %FS in the response to a modest change in contractility. However, caution must be exercised for assessment of ESPVR and E max in small LV cavities because of possible malpositioning of catheter electrodes above the aortic valve. Moreover, HR has a substantial effect on murine LV performance at subphysiological HRs and HR max must be used in the evaluation of cardiac function.
Limitations
All measurements in this study are performed during acute changes in contractility. Whereas it is well known that end-systolic indexes derived from P-V relations are changed by chronic changes in volume and mass regardless of contractility in larger animals (15, 18) , how this concept applies to genetically altered mice with chronic cardiovascular changes awaits further study. Alternatively, to eliminate the load dependency and geometrical effect on the end-systolic parameters (chamber physiology), it might be better to define myocardial tissue contractile properties, such as end-systolic stiffness, by transforming the P-V relationship into the stress-strain relationship (3, 15) .
